Evidence map›Paper›PMID 40530801›Full record

ArticleThe Journal of pathology2025

Development and characterisation of improved unifocal primary mouse lung cancer models with metastatic potential.

Ana-Rita Pedrosa, Alejandro Castillo-Kauil, Yuliia Kravchuk, Louise Reynolds, Bruce Williams, David Moore, Cameron Lang, Srinivas Allanki, Eleni Maniati, Alexandros Hardas and 11 more

Erratum issuedAbstract read
In one paragraph

Article in The Journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Ana-Rita PedrosaAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.ORCID 0000-0002-4421-6968
Alejandro Castillo-KauilAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Yuliia KravchukAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Louise ReynoldsAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Bruce WilliamsAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
David MooreDepartment of Pathology, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
Cameron LangImaging Therapies and Cancer, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Srinivas AllankiTumour Cell Biology Lab, The Francis Crick Institute, London, UK.
Eleni ManiatiCentre for Cancer Evolution, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Alexandros HardasRoyal Veterinary College, Hertfordshire, UK.ORCID 0000-0001-9906-7552
Jozafina HajAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Rebecca DrakeAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Julie CleaverCancer Imaging Lab, Centre for Cancer Biomarkers and Biotherapeutics, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Julie FosterCancer Imaging Lab, Centre for Cancer Biomarkers and Biotherapeutics, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Jana KimCancer Imaging Lab, Centre for Cancer Biomarkers and Biotherapeutics, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Ester SternDepartment of Cardiothoracic Surgery, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Jane SosabowskiCancer Imaging Lab, Centre for Cancer Biomarkers and Biotherapeutics, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Gilbert O FruhwirthImaging Therapies and Cancer, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Erik SahaiTumour Cell Biology Lab, The Francis Crick Institute, London, UK.
Ori WaldDepartment of Cardiothoracic Surgery, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Kairbaan Hodivala-DilkeAdhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.

Funding

Barts Charity Strategic Fund (ACK)Cancer Research UK/ RadNET CRUK City of London C48390/A21153(GOF)Cancer Research UK/ RadNET CRUK City of London C7893/A28990(A-RPandYK)Cancer Research UK/ RadNET CRUK City of London CTRQQR-2021\100004(JC,JF,JKandJS)Cancer Research UK/ RadNET CRUK City of London DRCNPG-May21|100004(BCICorefacilities)European Molecular Biology Organization ALTF922-2022(SA)Human Frontier Science Program LT0010/2023-L(SA)Medical Research Council MR/V009621/1(A-RP)Wellcome TrustWellcome Trust WT203148/Z/16/Z(GOF)Worldwide Cancer Research 16-1153(GOF)
6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-related death globally. To better understand the biology of lung cancer, mouse models have been developed using either tail vein-injected tumour cell lines or genetically modified mice. The current gold-standard models typically present with multiple lung foci. However, although these models are widely used, their correlation with human disease are limited, as early-stage human lung cancer usually presents as a single lesion rather than multiple foci. Additionally, a major challenge of using multifocal lung tumour models is the difficulty in distinguishing primary lung tumours from intrathoracic metastasis and lethal levels of lung congestion before distant metastases develop. Here, we present a refined and detailed surgical method in which murine tumour cells [Lewis lung carcinoma (LLC), alveogenic lung carcinoma (CMT), or Kras/Trp53-KP mutant cells] were injected directly into the left lung lobe of C57BL/6 mice, or, alternatively, adenoviral-Cre or adenoviral-FlpO was administered directly into the left lung lobe of Kras

Indexed as

Carcinoma, Lewis LungDisease Models, AnimalLung NeoplasmsAnimalsCell Line, TumorFemaleMiceMice, Inbred C57BLNeoplasm MetastasisProto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins p21(ras)histopathological featuresimmune infiltrationlung cancermatrix remodellingmetastasisnon‐small cell lung cancer (NSCLC) preclinical mouse modelssodium iodide symporterSPECT/CTUnifocal

Identifiers

PMID40530801
PMCPMC12256383

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.